Product NDC: | 0169-0092 |
Proprietary Name: | PrandiMet |
Non Proprietary Name: | repaglinide and metformin hydrochloride |
Active Ingredient(s): | 500; 2 mg/1; mg/1 & nbsp; repaglinide and metformin hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0169-0092 |
Labeler Name: | Novo Nordisk |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022386 |
Marketing Category: | NDA |
Start Marketing Date: | 20090115 |
Package NDC: | 0169-0092-01 |
Package Description: | 1 BOTTLE, PLASTIC in 1 CARTON (0169-0092-01) > 100 TABLET in 1 BOTTLE, PLASTIC |
NDC Code | 0169-0092-01 |
Proprietary Name | PrandiMet |
Package Description | 1 BOTTLE, PLASTIC in 1 CARTON (0169-0092-01) > 100 TABLET in 1 BOTTLE, PLASTIC |
Product NDC | 0169-0092 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | repaglinide and metformin hydrochloride |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20090115 |
Marketing Category Name | NDA |
Labeler Name | Novo Nordisk |
Substance Name | METFORMIN HYDROCHLORIDE; REPAGLINIDE |
Strength Number | 500; 2 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes | Glinide [EPC],Potassium Channel Antagonists [MoA],Biguanide [EPC],Biguanides [Chemical/Ingredient] |